Delayed cerebral ischemia (DCI) and aneurysm rebleeding contribute to morbidity and mortality in aneurysmal subarachnoid hemorrhage (aSAH); however, the relationship between their impacts on overall functional outcome is incompletely understood.
The authors conducted a cohort study of all aSAH during the study period from 2001 to 2016. Primary end points were overall functional outcome and ischemic aSAH sequelae, defined as delayed cerebral ischemia (DCI), DCI with infarction, symptomatic vasospasm (SV), and global cerebral edema (GCE). Outcomes were compared between the rebleed and nonrebleed cohorts overall and after propensity-score matching (PSM) for risk factors and treatment modality. Univariate and multivariate ordered logistic regression analyses for functional outcomes were performed in the PSM cohort to identify predictors of poor outcome.
Four hundred fifty-five aSAH cases admitted within 24 hours of aneurysm rupture were included, of which 411 (90%) experienced initial aneurysm ruptures only, while 44 (10%) had clinically confirmed rebleeding. In the overall cohort, rebleeding was associated with significantly worse functional outcome, longer intensive care unit length of stay (LOS), and GCE (all p < 0.01); treatment modality, overall LOS, DCI, DCI with infarction, and SV were nonsignificant. In the PSM analysis of 43 matched rebleed and 43 matched nonrebleed cases, only poor functional outcome and GCE remained significantly associated with rebleeding (p < 0.01 and p = 0.02, respectively). Multivariate regression identified that both rebleeding (HR 21.5, p < 0.01) and DCI (HR 10.1, p = 0.01) independently predicted poor functional outcome.
Rebleeding and DCI after aSAH are highly morbid and potentially deadly events after aSAH, which appear to have independent negative impacts on overall functional outcome. Early rebleeding did not significantly affect the risk of delayed ischemic complications.
ABBREVIATIONSACA = anterior cerebral artery; ACoA = anterior communicating artery; aSAH = aneurysmal subarachnoid hemorrhage; CI = confidence interval; DCI = delayed cerebral ischemia; EVD = external ventricular drain; GCE = global cerebral edema; GCS = Glasgow Coma Scale; ICA = internal carotid artery; ICU = intensive care unit; LOS = length of stay; MCA = middle cerebral artery; mRS = modified Rankin Scale; PSM = propensity-score matching; RI = radiological infarction; SV = symptomatic vasospasm; VPS = ventriculoperitoneal shunt; WFNS = World Federation of Neurosurgical Societies.
BadautJBrunetJFGrollimundLHamouMFMagistrettiPJVillemureJG: Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. Acta Neurochir Suppl86:495–4982003
BadautJ, BrunetJF, GrollimundL, HamouMF, MagistrettiPJ, VillemureJG, : Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. 86:495–498, 200314753493)| false
BellJDRhindSGDi BattistaAPMacdonaldRLBakerAJ: Biomarkers of glycocalyx injury are associated with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage: a case series supporting a new hypothesis. Neurocrit Care26:339–3472017
BellJD, RhindSG, Di BattistaAP, MacdonaldRL, BakerAJ: Biomarkers of glycocalyx injury are associated with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage: a case series supporting a new hypothesis. 26:339–347, 20172800013210.1007/s12028-016-0357-4)| false
BroderickJP, BrottTG, DuldnerJE, TomsickT, LeachA: Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. 25:1342–1347, 199410.1161/01.STR.25.7.13428023347)| false
DangB, ShenH, LiH, ZhuM, GuoC, HeW: Matrix metalloproteinase 9 may be involved in contraction of vascular smooth muscle cells in an in vitro rat model of subarachnoid hemorrhage. 14:4279–4284, 201610.3892/mmr.2016.5736)| false
DoerflerS, FaerberJ, McKhannGM, ElliottJP, WinnHR, KumarM, : The incidence and impact of secondary cerebral insults on outcome after aneurysmal subarachnoid hemorrhage. 114:e483–e494, 201810.1016/j.wneu.2018.02.195)| false
EtminanNChangHSHackenbergKde RooijNKVergouwenMDIRinkelGJE: Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol76:588–5972019
EtminanN, ChangHS, HackenbergK, de RooijNK, VergouwenMDI, RinkelGJE, : Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. 76:588–597, 201910.1001/jamaneurol.2019.0006)| false
FronteraJA, FernandezA, SchmidtJM, ClaassenJ, WartenbergKE, BadjatiaN, : Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?40:1963–1968, 200910.1161/STROKEAHA.108.54470019359629)| false
GrinnonST, MillerK, MarlerJR, LuY, StoutA, OdenkirchenJ, : National Institute of Neurological Disorders and Stroke Common Data Element Project—approach and methods. 9:322–329, 201210.1177/174077451243898022371630)| false
HohBLTopcuogluMASinghalABPryorJCRabinovJDRordorfGA: Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery55:779–7892004
JośkoJGwóźdźBHendrykSJedrzejowska-SzypułkaHSłowińskiJJochemJ: Expression of vascular endothelial growth factor (VEGF) in rat brain after subarachnoid haemorrhage and endothelin receptor blockage with BQ-123. Folia Neuropathol39:243–2512001
JośkoJ, GwóźdźB, HendrykS, Jedrzejowska-SzypułkaH, SłowińskiJ, JochemJ: Expression of vascular endothelial growth factor (VEGF) in rat brain after subarachnoid haemorrhage and endothelin receptor blockage with BQ-123. 39:243–251, 200111928895)| false
LordAS, FernandezL, SchmidtJM, MayerSA, ClaassenJ, LeeK, : Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhage. 78:31–37, 20122217089010.1212/WNL.0b013e31823ed0a4)| false
SheaAM, ReedSD, CurtisLH, AlexanderMJ, VillaniJJ, SchulmanKA: Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. 61:1131–1138, 200710.1227/01.neu.0000306090.30517.ae18162891)| false
SteigerHJFritschiJSeilerRW: Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. Acta Neurochir (Wien)127:21–261994
SteigerHJ, FritschiJ, SeilerRW: Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. 127:21–26, 199410.1007/BF018085417942176)| false
VergouwenMDVermeulenMvan GijnJRinkelGJWijdicksEFMuizelaarJP: Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke41:2391–23952010
VergouwenMD, VermeulenM, van GijnJ, RinkelGJ, WijdicksEF, MuizelaarJP, : Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. 41:2391–2395, 201010.1161/STROKEAHA.110.58927520798370)| false
ZhaoB, YangH, ZhengK, LiZ, XiongY, TanX, : Predictors of good functional outcomes and mortality in patients with severe rebleeding after aneurysmal subarachnoid hemorrhage. 144:28–32, 20162696308710.1016/j.clineuro.2016.02.042)| false